Correction: Liu et al. Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med. 2023, 12 , 1861.

Authors :: Liu Y
Wang CL
Pang ZQ
Gao K
Shen LK
Xu WH
Ren MH
Source :: Journal of clinical medicine [J Clin Med] 2024 Jul 05; Vol. 13 (13). Date of Electronic Publication: 2024 Jul 05.
Publication Year :: 2024
Abstract: In the original publication [...].

Full Text Access

Tools